Gamida Cell Stock Predictions

Healthcare > Biotechnology

Buy GMDA

*Your capital is at risk

$0.0327

+0 (+0%)

At Close: Aug 27, 2024

Currently predicting for Mon, 8 Jun 2026

GMDA Prediction Chart

GMDA Predictions History

Latest community submissions for GMDA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
David.Pierce.8003	Nov 19, 2020	Bearish	$6.84	X	—	0
Steven Franke @StevenFranke.178363	Nov 19, 2020	Bullish	$6.84	X	—	1
JS Pro	Nov 16, 2020	$5.88 -5.16%	$6.20	X	94.84%	0
jaakkoestama	Nov 16, 2020	Bearish	$6.20	X	—	1
JS Pro	Jun 22, 2020	$5.21 +5.68%	$4.93	X	94.32%	0
Alan Pro @Alan.115878	Jun 22, 2020	$5.16 +4.67%	$4.93	X	95.33%	0
JS Pro	Jun 12, 2020	$4.75 +0.00%	$4.75	X	100.00%	10
2poJeff Pro	Jun 12, 2020	$4.75 +0.00%	$4.75	X	100.00%	10
Mitch27	Jun 12, 2020	Bearish	$4.75	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GMDA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GAMIDA CELL LTD.

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by